Post-authorization efficacy and safety study of treatment with fixed-dose combination of perindopril and amlodipine (Amlessa) in patients with arterial hypertension and the impact of additional risk factors for cardiovascular diseases on patient compliance (COMPLIANT)

1. PDF datoteka (204 kB)

1. TXT datoteka (31 kB)

Izvoz v EndNote (RIS format)

Avtor(ji)

Rotar-Pavlič, Danica (avtor)
Kitak, Teja (avtor)
Barbič-Žagar, Breda (avtor)

Jezik

slovenski

Vir

Medicinski razgledi

Leto

2016

Številčenje

letnik 55, številka 4

Vsebina

arterijska hipertenzija zdravljenje zdravila

Založnik

Medicinski razgledi

Izvor

Društvo Medicinski razgledi
(Obvezni izvod spletne publikacije)

Pravice

URN

URN:NBN:SI:DOC-X5K7DTUS

COBISSID

33066457

Objavljeno

14.03.2018

Metapodatki

Citiranje

APA:

Rotar-Pavlič, Danica, Kitak, Teja, Barbič-Žagar, Breda (2016). Post-authorization efficacy and safety study of treatment with fixed-dose combination of perindopril and amlodipine (Amlessa) in patients with arterial hypertension and the impact of additional risk factors for cardiovascular diseases on patient compliance (COMPLIANT). Medicinski razgledi, letnik 55, številka 4, str. 487-496. URN:NBN:SI:DOC-X5K7DTUS from http://www.dlib.si

MLA:

Rotar-Pavlič, Danica, Kitak, Teja, Barbič-Žagar, Breda. "Post-authorization efficacy and safety study of treatment with fixed-dose combination of perindopril and amlodipine (Amlessa) in patients with arterial hypertension and the impact of additional risk factors for cardiovascular diseases on patient compliance (COMPLIANT)." Medicinski razgledi letnik 55. številka 4 (2016) str. 487-496.
<http://www.dlib.si/?URN=URN:NBN:SI:DOC-X5K7DTUS>

Medicinski razgledi
1962-
(Zbirni zapis)